Related Experiment Video

Updated: Jul 3, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

[Secondary prevention after myocardial infarction]

J E Pflumm1, T Pomykaj, M P Heintzen

  • 1Medizinische Klinik 2, Städtisches Klinikum Braunschweig gGmbH, Salzdahlumer Strasse 90, Braunschweig, Germany.

Der Internist
|July 25, 2008
PubMed

Insights

Reductions in cardiovascular mortality are linked to early coronary interventions and secondary prevention strategies. These strategies combine medical treatments like ACE inhibitors and statins with lifestyle changes such as diet and exercise.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Pharmacology

Context:

  • Cardiovascular mortality has significantly decreased over the past decade.
  • Advancements in early coronary intervention techniques and materials have reduced early mortality post-myocardial infarction.
  • Secondary prevention is crucial for continued progress in cardiovascular health.

Purpose:

  • To highlight the key components of secondary prevention for cardiovascular disease.
  • To outline evidence-based medical treatments and lifestyle modifications for post-myocardial infarction care.
  • To emphasize the role of pharmacotherapy and lifestyle in improving patient outcomes.

Summary:

  • Effective secondary prevention combines evidence-based medical treatments and lifestyle modifications.
  • Pharmacological interventions include ACE inhibitors, angiotensin receptor blockers, beta-blockers, statins, acetylsalicylic acid, and clopidogrel.
  • Lifestyle modifications encompass a healthy diet, moderate physical activity, weight reduction, and smoking cessation.

Impact:

  • Improved management of elevated blood pressure, left ventricular remodeling, and electrical stability.
  • Enhanced lipid profiles through statin therapy (decreased LDL, increased HDL).
  • Reduced thrombotic events via antiplatelet therapy with acetylsalicylic acid and clopidogrel.
  • Positive outcomes from lifestyle changes contributing to overall cardiovascular health.

More Related Videos

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...